Theraclion S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALTHE.PA research report →
About the company
Theraclion SA, established in 2004 and based in Malakoff, France, specializes in developing innovative echotherapy medical solutions. These treatments harness high-intensity focused ultrasound (HIFU) technology. Their offerings include SONOVEIN, a robotic, non-surgical echotherapy system designed for addressing varicose veins, and ECHOPULSE, a similar robotic, non-invasive solution for treating thyroid nodules and breast fibroadenoma.
- CEO
- Martin Deterre
- IPO
- 2014
- Employees
- 28
- HQ
- Malakoff, FR
Price Chart
- Market Cap
- $31.13M
- P/E
- -6.06
- P/S
- 26.25
- P/B
- -14.83
- EV/EBITDA
- -5.62
- Div Yield
- 0.00%
- Gross Margin
- -528.16%
- Op Margin
- -424.37%
- Net Margin
- -479.76%
- ROE
- 222.05%
- ROIC
- -49.80%
- Revenue
- $1.19M · 42.89%
- Net Income
- $-5,690,000 · 1.16%
- EPS
- $-0.10 · 18.50%
- Op Income
- $-6,374,000
- FCF YoY
- 0.00%
- 52W High
- $1.25
- 52W Low
- $0.30
- 50D MA
- $0.59
- 200D MA
- $0.62
- Beta
- 0.36
- Avg Volume
- 193.61K
Get TickerSpark's AI analysis on ALTHE.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALTHE.PA coverage
Recent articles, reports, and earnings notes.
No research on ALTHE.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALTHE.PA report →Similar companies
Peers in the same neighborhood.